Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.49 |
| ▸ | XIAP | P98170 | 1/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 9/20 | 0.45 |
| ▸ | NTSR1 | P30989 | 9/20 | 0.45 |
| ▸ | SORT1 | Q99523 | 9/20 | 0.45 |
| ▸ | CALCRL | Q16602 | 3/20 | 0.44 |
| ▸ | GRB2 | P62993 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8970642 | 0.97 | EPHA2 (0.47) | EPHA2XIAPNTSR2NTSR1SORT1 | |
| SCHEMBL10378950 | 0.94 | EPHA2 (0.48) | EPHA2XIAPNTSR2NTSR1SORT1 | |
| SCHEMBL10378224 | 0.94 | EPHA2 (0.48) | EPHA2XIAPNTSR2NTSR1SORT1 | |
| SCHEMBL10533153 | 0.91 | EPHA2 (0.49) | EPHA2XIAPNTSR2NTSR1SORT1 | |
| SCHEMBL10378610 | 0.89 | EPHA2 (0.49) | EPHA2NTSR2NTSR1SORT1CALCRL | |
| SCHEMBL30676238 | 0.89 | EPHA2 (0.46) | EPHA2XIAPNTSR2NTSR1SORT1 | |
| SCHEMBL7788531 | 0.88 | CXCR4 (0.45) | EPHA2XIAPNTSR2NTSR1SORT1 | |
| SCHEMBL30118981 | 0.88 | EPHA2 (0.47) | EPHA2CALCRLGRB2 | |
| SCHEMBL9551316 | 0.88 | EPHA2 (0.59) | EPHA2NTSR2NTSR1SORT1CALCRL | |
| SCHEMBL29466793 | 0.87 | EPHA2 (0.47) | EPHA2CALCRLKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0502926-B1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE POULENC RORER INT (US) | 1996-03-13 | — | — | EP | claimed |
| EP-0502926-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INT (US) | 1992-09-16 | — | — | EP | claimed |
| EP-0502926-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES. | RHONE POULENC RORER INTERNAT H (US) | 1992-07-13 | — | — | EP | claimed |
| US-5053392-A | Anticoagulants | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-01 | — | — | US | claimed |
| WO-1991007976-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-06-13 | — | — | WO | claimed |
| EP-0502926-B1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE POULENC RORER INT (US) | 1996-03-13 | — | — | EP | disclosed |
| US-5053392-A | Anticoagulants | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-01 | — | — | US | disclosed |